Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Placebo Controlled Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

NCT02215330 is registered in ClinicalTrials.gov with Prim. Prof. Dr. Oliver Findl, MBA as lead sponsor.

NCT NCT02215330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Placebo Controlled Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Lead sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2014
Completion date
September 30, 2017
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy